● Recruiting

Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study

Condition: Endometrial Cancer · Sponsor: Centre Francois Baclesse

PhaseN/A

Planned participants16

Who can joinFemale, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study comprises 3 stages: 1. Collection of tumor and blood samples. 2. Creation of organoid models based on tumor samples. 3. Development of functional tests to predict clinical response to treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Gwenn LE GALL, Medical Doctor · +33231455050 · g.legall@baclesse.unicancer.fr

François CHERIFI, Medical Doctor · 33231455050 · f.cherifi@baclesse.unicancer.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Centre François Baclesse

Caen, France

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06603506